The major limitation in the use of clozapine for
treatment of schizophrenia is:
A. Its potential to cause agranulocytosis
B. Its inability to benefit negative symptoms of
schizophrenia
C. High incidence of extrapyramidal side effects
treatment of schizophrenia is:
A. Its potential to cause agranulocytosis
B. Its inability to benefit negative symptoms of
schizophrenia
C. High incidence of extrapyramidal side effects